rs78705382
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_024570.4(RNASEH2B):c.412C>T(p.Leu138Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000428 in 1,612,556 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_024570.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251208Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135788
GnomAD4 exome AF: 0.0000466 AC: 68AN: 1460372Hom.: 0 Cov.: 29 AF XY: 0.0000482 AC XY: 35AN XY: 726604
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74334
ClinVar
Submissions by phenotype
not provided Pathogenic:1
The L138F variant in the RNASEH2B gene has been reported previously in the compound heterozygous state in multiple unrelated individuals with Aicardi-Goutieres syndrome (Rice et al., 2007; La Piana et al., 2014; Rice et al., 2013). The L138F variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The L138F variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position where amino acids with similar properties to Leucine are tolerated across species. Although in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function, RNASEH2B has a low rate of benign missense variation and missense variants are a common mechanism of disease (Stenson et al., 2014; Rice et al., 2007). Therefore, we interpret L138F as a likely pathogenic variant, however the possibility it may be a rare benign variant cannot be excluded. -
Aicardi-Goutieres syndrome 2 Uncertain:1
This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 138 of the RNASEH2B protein (p.Leu138Phe). This variant is present in population databases (rs78705382, gnomAD 0.005%). This missense change has been observed in individuals with Aicardi-Goutières syndrome (AGS) and atypical AGS (PMID: 17846997, 25343331). ClinVar contains an entry for this variant (Variation ID: 372780). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at